Sapience Therapeutics

Sapience Therapeutics

  • Founded: 2015
  • Location: Harrison, NY
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: ST101 
  • Product link:
  • Funding: $41M B May 2022; $22.5M A Jul 2016
  • Investors: NexPoint, Bristol Myers Squibb, Eshelman Ventures, Kingdon Capital

job board

Short description:

Peptide-based Therapies for cancers

Drug notes:

6 additional trials Clin2 multiple cancers; ST316 Clin1/Clin2 solid tumors; JunAP RD multiple cancers; FoxAP RD multiple cancers

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy